After nearly 10 years at the CEO post for GlaxoSmithKline, Andrew Witty is handing over the reins to a company that has been reshaped with a vaccines focus. And during Witty’s final full year at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results